Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

[Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report].

Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A.

Rev Med Interne. 2019 Apr;40(4):258-261. doi: 10.1016/j.revmed.2018.11.007. Epub 2018 Dec 11. French.

2.

T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.

Launois P, Drowart A, Bourreau E, Couppie P, Farber CM, Van Vooren JP, Huygen K.

Clin Dev Immunol. 2011;2011. pii: 640309. doi: 10.1155/2011/640309. Epub 2010 Sep 27.

3.

Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.

Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, Dediste A, Michel O, Drowart A, Allard SD, Doherty TM, Lecher S, Locht C, Mascart F.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):848-54. doi: 10.1164/rccm.201001-0083OC. Epub 2010 May 27.

PMID:
20508213
4.

Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.

Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, Debrie AS, Doherty TM, Van Vooren JP, Locht C, Mascart F.

PLoS One. 2007 Oct 3;2(10):e926.

5.

Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, Mascart F.

Am J Respir Crit Care Med. 2007 Aug 15;176(4):409-16. Epub 2007 May 31.

PMID:
17541018
6.

Lymphocytic pleural effusion associated with valproic acid.

André S, Drowart A, De Bels D.

Eur J Intern Med. 2005 Nov;16(7):535. No abstract available.

PMID:
16275557
7.

[Ovarian metastasis and lung adenocarcinoma: a case report].

Castadot P, Magné N, Berghmans T, Drowart A, Baeyens L, Smets D, Van Houtte P.

Cancer Radiother. 2005 May;9(3):183-6. Epub 2005 Apr 9. French.

PMID:
16023045
8.

Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin.

Temmerman S, Pethe K, Parra M, Alonso S, Rouanet C, Pickett T, Drowart A, Debrie AS, Delogu G, Menozzi FD, Sergheraert C, Brennan MJ, Mascart F, Locht C.

Nat Med. 2004 Sep;10(9):935-41. Epub 2004 Aug 8.

9.

Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis.

Masungi C, Temmerman S, Van Vooren JP, Drowart A, Pethe K, Menozzi FD, Locht C, Mascart F.

J Infect Dis. 2002 Feb 15;185(4):513-20. Epub 2002 Jan 31.

PMID:
11865404
10.

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K.

Int J Cancer. 2000 Sep 15;87(6):844-52.

11.

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

Zlotta AR, van Vooren JP, Huygen K, Drowart A, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Simon J, Schulman CC.

Eur Urol. 2000 Apr;37(4):470-7.

PMID:
10765079
12.
13.

Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy.

Zlotta AR, Drowart A, Van Vooren JP, Shekarsarai H, De Cock M, Pirson M, Palfliet K, Jurion F, Simon J, Schulman CC, Huygen K.

J Urol. 1998 Jun;159(6):1885-91.

PMID:
9598481
14.

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.

Lozes E, Denis O, Drowart A, Jurion F, Palfliet K, Vanonckelen A, De Bruyn J, De Cock M, Van Vooren JP, Huygen K.

Scand J Immunol. 1997 Jul;46(1):16-26.

15.

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.

Zlotta AR, Drowart A, Huygen K, De Bruyn J, Shekarsarai H, Decock M, Pirson M, Jurion F, Palfliet K, Denis O, Mascart F, Simon J, Schulman CC, Van Vooren JP.

Clin Exp Immunol. 1997 Jul;109(1):157-65.

16.

Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).

Drowart A, Cambiaso CL, Huygen K, Serruys E, Portaels F, Jann E, Van Vooren JP.

Int J Tuberc Lung Dis. 1997 Jun;1(3):284-8.

PMID:
9432378
17.

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

Lozes E, Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Vandenbussche P, Van Vooren JP, Drowart A, Ulmer JB, Liu MA.

Vaccine. 1997 Jun;15(8):830-3.

PMID:
9234526
18.

[The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].

Shekarsarai H, Zlotta AR, Drowart A, Van Vooren JP, De Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.

Acta Urol Belg. 1997 Mar;65(1):1-4. French.

PMID:
9245197
19.

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.

Zlotta AR, Drowart A, Van Vooren JP, de Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.

J Urol. 1997 Feb;157(2):492-8.

PMID:
8996341
20.

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, Drowart A, Lozes E, Vandenbussche P, Van Vooren JP, Liu MA, Ulmer JB.

Nat Med. 1996 Aug;2(8):893-8.

PMID:
8705859
21.

Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts.

Launois P, N'Diaye MN, Cartel JL, Mane I, Drowart A, Van Vooren JP, Sarthou JL, Huygen K.

Infect Immun. 1995 Jan;63(1):88-93.

22.

IgG humoral response against the antigen 85 complex homologues in leprosy.

Drowart A, Huygen K, Launois P, Jann E, Nyabenda J, van Vooren JP.

Scand J Immunol. 1994 Dec;40(6):643-7.

PMID:
7997854
23.

Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.

Zlotta A, Drowart A, van Vooren JP, Simon J, Schulman CC, Huygen K.

Acta Urol Belg. 1994 Sep;62(3):63-8.

PMID:
7976857
24.

T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy.

Launois P, DeLeys R, Niang MN, Drowart A, Andrien M, Dierckx P, Cartel JL, Sarthou JL, Van Vooren JP, Huygen K.

Infect Immun. 1994 Sep;62(9):3679-87.

25.

Detection of anti-85A and anti-85B IgG antibodies in HIV-infected patients with active pulmonary tuberculosis.

Van Vooren JP, Launois P, Huygen K, Leguenno B, Drowart A.

Eur J Clin Microbiol Infect Dis. 1994 May;13(5):444-6. No abstract available.

PMID:
8070466
26.

T cell reactivity against antigen 85 but not against the 18- and 65-kD heat shock proteins in the early stages of acquired immunity against Mycobacterium leprae.

Launois P, Niang N'Diaye M, Sarthou JL, Drowart A, Van Vooren JP, Cartel JL, Huygen K.

Clin Exp Immunol. 1994 Apr;96(1):86-90.

27.

IgG response to purified 65- and 70-kDa mycobacterial heat shock proteins and to antigen 85 in leprosy.

Launois P, N'Diaye Niang M, Drowart A, Van Vooren JP, Sarthou JL, Lalu T, Millan J, Huygen K.

Int J Lepr Other Mycobact Dis. 1994 Mar;62(1):48-54.

PMID:
8189089
28.

Structure of the Mycobacterium tuberculosis antigen 88, a protein related to the Escherichia coli PstA periplasmic phosphate permease subunit.

Braibant M, De Wit L, Peirs P, Kalai M, Ooms J, Drowart A, Huygen K, Content J.

Infect Immun. 1994 Mar;62(3):849-54.

29.

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG.

Huygen K, Lozes E, Gilles B, Drowart A, Palfliet K, Jurion F, Roland I, Art M, Dufaux M, Nyabenda J, et al.

Infect Immun. 1994 Feb;62(2):363-70.

30.

T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen.

Launois P, Niang MN, Sarthou JL, Rivier F, Drowart A, Van Vooren JP, Millan J, Huygen K.

Scand J Immunol. 1993 Aug;38(2):167-76.

PMID:
8346416
31.

Detection of mycobacterial antigens present in short-term culture media using particle counting immunoassay.

Drowart A, Cambiaso CL, Huygen K, Serruys E, Yernault JC, Van Vooren JP.

Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1401-6.

PMID:
8503551
32.
33.

IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy.

Launois P, Vandenbussche P, M'Bayame NN, Drowart A, Van Vooren JP, Sarthou JL, Millan J, Huygen K.

Cell Immunol. 1993 May;148(2):283-90.

PMID:
8495494
34.

The major secreted antigen complex (Ag 85) from Mycobacterium bovis bacille Calmette-Guérin is associated with protective T cells in leprosy: a follow-up study of 45 household contacts.

Launois P, Niang MN, De Bruyn J, Sarthou JL, Rivier F, Drowart A, Van Vooren JP, Millan J, Huygen K.

J Infect Dis. 1993 May;167(5):1160-7.

PMID:
8486949
35.

Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.

Drowart A, Chanteau S, Huygen K, De Cock M, Cartel JL, De Bruyn J, Launois P, Yernault JC, Van Vooren JP.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):29-34.

PMID:
8326178
36.

Disposition of liposomal gentamicin following intrabronchial administration in rabbits.

Demaeyer P, Akodad EM, Gravet E, Schietecat P, Van Vooren JP, Drowart A, Yernault JC, Legros FJ.

J Microencapsul. 1993 Jan-Mar;10(1):77-88.

PMID:
8445509
37.

Absence of IgM and IgG antibody response to the three components of the Mycobacterium bovis BCG 85 complex antigen after BCG vaccination.

Drowart A, Selleslagls J, Huygen K, De Bruyn J, Van Vooren JP.

Chest. 1993 Jan;103(1):320-1. No abstract available.

PMID:
8417920
38.

Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex.

Drowart A, De Bruyn J, Huygen K, Damiani G, Godfrey HP, Stelandre M, Yernault JC, Van Vooren JP.

Scand J Immunol. 1992 Nov;36(5):697-702.

PMID:
1439581
39.

Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.

Huygen K, Abramowicz D, Vandenbussche P, Jacobs F, De Bruyn J, Kentos A, Drowart A, Van Vooren JP, Goldman M.

Infect Immun. 1992 Jul;60(7):2880-6.

40.

Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis.

Van Vooren JP, Drowart A, De Bruyn J, Launois P, Millan J, Delaporte E, Develoux M, Yernault JC, Huygen K.

J Clin Microbiol. 1992 Jun;30(6):1608-10.

41.

The humoral immune response after BCG vaccination: an immunoblotting study using two purified antigens.

Drowart A, Selleslaghs J, Yernault JC, Valcke C, De Bruyn J, Huygen K, Farber CM, Van Vooren JP.

Tuber Lung Dis. 1992 Jun;73(3):137-40.

PMID:
1421345
42.

Evolution of osteocalcin, alkaline phosphatase and parathyroid hormone after parathyroidectomy in patients receiving chronic maintenance hemodialysis.

Peretz AM, Dhaene MM, Drowart A, Kinnaert P, Vertongen FM, Bourdoux PP.

J Rheumatol. 1992 Mar;19(3):411-5.

PMID:
1578455
43.

An isoelectric focusing method for the study of the humoral response against the antigen 85 complex of Mycobacterium bovis BCG in the different forms of leprosy.

Drowart A, Launois P, De Cock M, Huygen K, De Bruyn J, Yernault JC, Van Vooren JP.

J Immunol Methods. 1991 Dec 15;145(1-2):223-8.

PMID:
1765655
44.

Humoral immune response of tuberculous patients against the three components of the Mycobacterium bovis BCG 85 complex separated by isoelectric focusing.

Van Vooren JP, Drowart A, De Cock M, Van Onckelen A, D'Hoop MH, Yernault JC, Valcke C, Huygen K.

J Clin Microbiol. 1991 Oct;29(10):2348-50.

45.

Antibody levels to whole culture filtrate antigens and to purified P32 during treatment of smear-positive tuberculosis.

Drowart A, Huygen K, De Bruyn J, Yernault JC, Farber CM, Van Vooren JP.

Chest. 1991 Sep;100(3):685-7.

PMID:
1889257

Supplemental Content

Loading ...
Support Center